AUPQ415899A0 - Compositions for and methods of treatment of allergic diseases - Google Patents

Compositions for and methods of treatment of allergic diseases

Info

Publication number
AUPQ415899A0
AUPQ415899A0 AUPQ4158A AUPQ415899A AUPQ415899A0 AU PQ415899 A0 AUPQ415899 A0 AU PQ415899A0 AU PQ4158 A AUPQ4158 A AU PQ4158A AU PQ415899 A AUPQ415899 A AU PQ415899A AU PQ415899 A0 AUPQ415899 A0 AU PQ415899A0
Authority
AU
Australia
Prior art keywords
compositions
treatment
methods
allergic diseases
allergic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPQ4158A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VASSE RESEARCH INSTITUTE Pty Ltd
Original Assignee
VASSE RES INST Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VASSE RES INST Pty Ltd filed Critical VASSE RES INST Pty Ltd
Priority to AUPQ4158A priority Critical patent/AUPQ415899A0/en
Publication of AUPQ415899A0 publication Critical patent/AUPQ415899A0/en
Priority to CN00815855A priority patent/CN1391480A/en
Priority to AU13734/01A priority patent/AU782689B2/en
Priority to BR0015698-1A priority patent/BR0015698A/en
Priority to CA002391499A priority patent/CA2391499A1/en
Priority to JP2001539479A priority patent/JP2003514869A/en
Priority to KR1020027006409A priority patent/KR20020084066A/en
Priority to EP00975685A priority patent/EP1229930A4/en
Priority to PCT/AU2000/001414 priority patent/WO2001037865A1/en
Priority to HK03100999.8A priority patent/HK1049115A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/07—Bacillus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6866—Interferon
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/113—Acidophilus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/125—Casei
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/335—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Lactobacillus (G)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AUPQ4158A 1999-11-19 1999-11-19 Compositions for and methods of treatment of allergic diseases Abandoned AUPQ415899A0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
AUPQ4158A AUPQ415899A0 (en) 1999-11-19 1999-11-19 Compositions for and methods of treatment of allergic diseases
PCT/AU2000/001414 WO2001037865A1 (en) 1999-11-19 2000-11-20 Compositions and methods for treatment of allergic disorders
CA002391499A CA2391499A1 (en) 1999-11-19 2000-11-20 Compositions and methods for treatment of allergic disorders
AU13734/01A AU782689B2 (en) 1999-11-19 2000-11-20 Compositions and methods for treatment of allergic disorders
BR0015698-1A BR0015698A (en) 1999-11-19 2000-11-20 Compositions and methods for treating allergic diseases
CN00815855A CN1391480A (en) 1999-11-19 2000-11-20 Compositions and methods for treatment of allergic disorders
JP2001539479A JP2003514869A (en) 1999-11-19 2000-11-20 Compositions and methods for the treatment of allergic diseases
KR1020027006409A KR20020084066A (en) 1999-11-19 2000-11-20 Compositions and Methods for Treatment of Allergic Disorders
EP00975685A EP1229930A4 (en) 1999-11-19 2000-11-20 Compositions and methods for treatment of allergic disorders
HK03100999.8A HK1049115A1 (en) 1999-11-19 2003-02-11 Compositions and methods for treatment of allergic disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPQ4158A AUPQ415899A0 (en) 1999-11-19 1999-11-19 Compositions for and methods of treatment of allergic diseases

Publications (1)

Publication Number Publication Date
AUPQ415899A0 true AUPQ415899A0 (en) 1999-12-16

Family

ID=3818302

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPQ4158A Abandoned AUPQ415899A0 (en) 1999-11-19 1999-11-19 Compositions for and methods of treatment of allergic diseases

Country Status (9)

Country Link
EP (1) EP1229930A4 (en)
JP (1) JP2003514869A (en)
KR (1) KR20020084066A (en)
CN (1) CN1391480A (en)
AU (1) AUPQ415899A0 (en)
BR (1) BR0015698A (en)
CA (1) CA2391499A1 (en)
HK (1) HK1049115A1 (en)
WO (1) WO2001037865A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID29150A (en) 1999-01-15 2001-08-02 Entpr Ireland Cs USE OF LACTOBACILLUS SALIVARIUS
FI110668B (en) 2000-06-20 2003-03-14 Aboatech Ab Oy Use of probiotics for primary prevention of atopic diseases
PE20030283A1 (en) * 2001-07-26 2003-05-01 Alimentary Health Ltd LACTOBACILLUS CASEI STRAINS
GB0124580D0 (en) 2001-10-12 2001-12-05 Univ Reading New composition
JP4212838B2 (en) * 2002-06-26 2009-01-21 カルピス株式会社 Antiallergic agent
CN1767839B (en) * 2003-03-13 2012-08-22 麒麟控股株式会社 Antiallergic composition
JP4712289B2 (en) * 2003-08-26 2011-06-29 株式会社エイ・エル・エイ Immune promoting composition
JP4591810B2 (en) * 2003-09-19 2010-12-01 日之出産業株式会社 Nasal composition for controlling hay fever allergic rhinitis
AU2004298384A1 (en) * 2003-12-17 2005-06-30 N.V. Nutricia Lactic acid producing bacteria and lung function
US7955834B2 (en) 2004-06-03 2011-06-07 Biogaia Ab Method for improved breast milk feeding to reduce the risk of allergy
TWI356680B (en) * 2007-01-05 2012-01-21 Promd Biotech Co Ltd Anti-allergy lactic acid bacteria
CN102657260B (en) * 2007-06-21 2013-08-21 东宇生物科技股份有限公司 Antiallergic lactobacillus
CN101328468B (en) * 2007-06-21 2012-05-23 东宇生物科技股份有限公司 Antiallergic lactic acid bacteria
EP2065048A1 (en) * 2007-11-30 2009-06-03 Institut Pasteur Use of a L. casei strain, for the preparation of a composition for inhibiting mast cell activation
PL2244734T3 (en) 2008-02-01 2017-01-31 Murdoch Childrens Research Institute A method of inducing tolerance to an allergen
JP6214395B2 (en) 2010-08-10 2017-10-18 アール．ピー． シェーラー テクノロジーズ エルエルシー Method for producing stable soft gel capsules containing microencapsulated probiotic bacteria
KR101311989B1 (en) * 2010-11-17 2013-09-26 주식회사한국야쿠르트 Products containing Lactobacillus casei HY7211 having immuno-regulatory and immuno-stimulatory functions as effective component
MX2020007032A (en) * 2018-01-12 2020-12-03 Gi Innovation Inc Composition comprising probiotics and polypeptide having binding affinity for ige and use thereof.
CN111296842B (en) * 2020-02-14 2021-01-05 赵一鸣 Probiotic composition with anti-allergy effect
CN112375722B (en) * 2021-01-18 2021-04-13 山东中科嘉亿生物工程有限公司 Lactobacillus casei LC-12 for improving allergy, and product and application thereof
WO2024081219A1 (en) 2022-10-14 2024-04-18 Csp Technologies, Inc. Container and method for storing and stabilizing moisture sensitive products
CN117085046A (en) * 2023-10-20 2023-11-21 潍坊君薇生物科技有限责任公司 Lactobacillus acidophilus LS001 metaplasia and application thereof
CN117887643B (en) * 2024-03-14 2024-06-14 微康益生菌(苏州)股份有限公司 Antiallergic probiotic and application thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5946488B2 (en) 1978-08-07 1984-11-13 極東脂肪酸株式会社 Allergic reaction inhibitor
JPS5946491B2 (en) 1979-03-14 1984-11-13 極東脂肪酸株式会社 Asthma treatment agent
JPH07265064A (en) 1993-11-23 1995-10-17 Taketoshi Yamada Composition for improving enterobacterial flora
JPH092959A (en) 1995-06-16 1997-01-07 Yakult Honsha Co Ltd Immuno-globulin e antibody production suppressant and antiallergic agent
EP0904784A1 (en) * 1997-09-22 1999-03-31 N.V. Nutricia Probiotic nutritional preparation
JPH11199495A (en) * 1998-01-10 1999-07-27 Nichinichi Seiyaku Kk Antiallergic agent using enteric capsule
IT1298918B1 (en) * 1998-02-20 2000-02-07 Mendes Srl USE OF ARGININE DEIMINASE BACTERIA TO INDUCE APOPTOSIS AND / OR REDUCE AN INFLAMMATORY REACTION AND PHARMACEUTICAL COMPOSITIONS
JP4074006B2 (en) * 1998-06-24 2008-04-09 アサマ化成株式会社 Method for producing IgE antibody production inhibitor and food using the same

Also Published As

Publication number Publication date
CA2391499A1 (en) 2001-05-31
KR20020084066A (en) 2002-11-04
HK1049115A1 (en) 2003-05-02
WO2001037865A1 (en) 2001-05-31
CN1391480A (en) 2003-01-15
EP1229930A1 (en) 2002-08-14
EP1229930A4 (en) 2004-09-22
BR0015698A (en) 2002-07-23
JP2003514869A (en) 2003-04-22

Similar Documents

Publication Publication Date Title
AUPQ415899A0 (en) Compositions for and methods of treatment of allergic diseases
AU2002324914A1 (en) Pharmaceutical compositions of drug-oligomer conjugates and methods of treating diseases therewith
AU2003257937A1 (en) Methods and compositions for treatment of dermal conditions
AUPR638101A0 (en) Composition and method for treatment of disease
WO2003072035A8 (en) Compositions and methods for the treatment of immune related diseases
AU7748000A (en) Method and composition for the treatment of dermatologic diseases
AU3998400A (en) Methods of treating c1s-mediated diseases and conditions, and compounds and compositions therefor
AU7880700A (en) Compositions and methods of treatment for skin conditions using extracts of turmeric
WO2004024097A9 (en) Compositions and methods for the treatment of immune related diseases
AU2003268531A1 (en) Materials and methods for treatment of allergic diseases
AU2002352533A1 (en) Methods and compositions for treatment of gastric diseases
AU7743100A (en) Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
AU3632600A (en) Compositions and methods for the treatment of immune related diseases
HUP0302718A3 (en) Methods and compositions for the treatment of diseases of the eye
EP1416795A4 (en) Compositions and methods for treatment of mitochondrial diseases
AU4511201A (en) Compositions and methods for the induction and treatment of retinal detachments
AU1953701A (en) Methods and compositions for treatment of inflammatory disease
AU2002366028A1 (en) Use of fk506 and analogues for treating allergic diseases
AU3434601A (en) Compositions and methods for the treatment of immune related diseases
AU3356000A (en) L-arginine based formulations for treating diseases and methods of using same
AU1405001A (en) Treatment of diseases
AU2001267165A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU4034800A (en) Novel compositions and methods for prevention and treatment of protozoal disease
HUP0204180A3 (en) External composition and its use for treating of allergic skin diseases
AU2001255168A1 (en) Compositions and methods for the treatment of immune related diseases

Legal Events

Date Code Title Description
NAA1 Application designating australia and claiming priority from australian document

Ref document number: 1373401

Country of ref document: AU